ATI Pharmacology Practice Exam A 2025
ii ii ii ii ii ii ii
(questions) verified correct answers latest
ii ii ii ii ii
update already pass 100% accurate
ii ii ii ii ii
ii
A iinurse iiis iiproviding iidischarge iiinstructions iito iia iiclient iiwho iihas iiheart iifailure iiand iia
iinew ii
ii
prescription iifor iicaptopril. iiWhich iiof iithe iifollowing iiclient iistatements iiindicates
iian
ii
understanding iiof iithe
iiteaching?
ii
a. "I iishould iitake iithis iimedication iiwith iifood." ii
b. "I iishould iitake iinaproxen iiif iiI iidevelop iijoint iipain." ii
c. "I iishould iitell iimy iiprovider iiif iiI iidevelop iia iisore iithroat." ii
d. "I iishould iiexpect iithe iimedication iito iicause iimy iiurine iito iilook iiorange." ii- iic. ii"I iishould
iitell iimy iiprovider iiif iiI iidevelop iia iisore iithroat." ii
ii
The iiclient iishould iireport iia iisore iithroat iito iithe iiprovider iibecause iithis iican iiindicate
iineutropenia, iia iiserious iiadverse iieffect iiof iicaptopril. iiNeutropenia iican iibe iireversed iiif iiit
iiis iiidentified iiearly iiand iithe iimedication iiis iipromptly iidiscontinued. ii
ii
A iinurse iiis iiproviding iiteaching iito iia iiclient iiwho iihas iipeptic iiulcer iidisease iiand iiis iito
iistart iia ii
new iiprescription iifor iisucralfate. iiWhich iiof iithe iifollowing iiactions iiof iisucralfate iishould
iithe ii
ii ii
nurse iiinclude iiin iithe
iiteaching?
ii
ii
a. iiDecreases iistomach iiacid iiand
iisecretion
ii
b. iiNeutralizes iiacid iiin iithe
iistomach
ii
c. iiForms iia iiprotective
iibarrier
d. iiTreats iiulcers iiby iieradicating iiH. iipylori ii- iiC. iiFor iia iia iiprotective iibarrier iiover
iiulcers
ii
Secretions iiby iithe iiparietal iichief iicells, iihydrochloric iiacid iiand iipepsin, iican iifurther
iiirritate ii
the iiulcerated iiareas. iiSucralfate, iia iimucosal iiprotectant, iiforms iia iigel-like iisubstance
iithat ii
ii
coats iithe iiulcer, iicreating iia iibarrier iito iihydrochloric iiacid iiand
iipepsin.
ii
,A iinurse iiis iiproviding iiteaching iito iia iiclient iiwho iihas iimultiple iisclerosis iiand iia iinew
iiprescription iifor iimethylprednisolone. iiWhich iiof iithe iifollowing iiinstructions iishould iithe
iinurse iiinclude? ii(SATA) ii
ii
a. Blood iiglucose iilevels iiwill iibe iimonitored iiduring iitherapy ii
b. Avoid iicontact iiwith iipeople iiwho iihave iiknown iiinfections ii
c. Take iithe iimedication ii1 iihr iibefore iibreakfast ii
d. Decrease iidietary iiintake iiof iifoods iicontaining iipotassium ii
e. Grapefruit iijuice iican iiincrease iithe iieffects iiof iithe iimedication ii- iia. iiBlood iiglucose
iilevels iiwill iibe iimonitored iiduring iitherapy ii
b. iiAvoid iicontact iiwith iipeople iiwho iihave iiknown iiinfections ii
e. iiGrapefruit iijuice iican iiincrease iithe iieffects iiof iithe iimedication ii
ii
a. The iinurse iishould iimonitor iithe iiclient iifor iihyperglycemia iiwhile iiproviding
iimethylprednisolone iito iithe iiclient. iiGlucocorticoids, iisuch iias iimethylprednisolone,
iiincrease iiserum iiglucose iilevels iiand iican iirequire iimanagement iiwith iiinsulin iior
iiantihyperglycemia. ii
b. The iinurse iishould iiinstruct iithe iiclient iito iiavoid iiexposures iito iiinfectious iiagents,
iisuch iias iicontact iiwith iithose iiwho iihave iiactive iiinfections iior iiillnesses. iiGlucocorticoids,
iiwhich iias iimethylprednisolone, iidepress iithe iiimmune iisystem, iiplacing iithe iiclient iiat iian
iiincreased iirisk iifor iideveloping iian iiinfection. ii
e. iiThe iinurse iishould iiin iistrict iithe iiclient iithat iigrapefruit iiand iigrapefruit iijuice iican
iiincrease iithe iilevel iiof iimethylprednisolone iiin iithe iibody. ii
ii
The iinurse iiis iiproviding iidischarge iiteaching iiabout iihandling iimedication iito iia iiclient iiwho
iiis ii
ii
to iicontinue iitaking iioral iitransmucosal iifentanyl iiraspberry-flavored iilozenges iion iia
iistick.
ii
Which iiof iithe iifollowing iiinformation iishould iithe iinurse iiinclude iiin iithe
iiteaching?
ii
a. Chew iion iithe iimedication iistick iito iirelease iithe iimedication ii
b. Leave iithe iimedication iistick iiin iione iilocation iiof iithe iimouth iiuntil iimelted ii
c. Allow iithe iimedication ii1 iihr iifor iithe iianalgesia iieffects iito iibegin ii
d. Store iiunused iimedication iisticks iiin iia iistorage iicontainer ii- iid. iiStore iiunused
iimedication iisticks iiin iia iistorage iicontainer ii
ii
The iinurse iishould iiinstruct iithe iiclient iito iistore iiunused, iior iipartially iiused, iimedications
iisticks ii
ii
in iithe iisafe iistorage iicontainer iithat iicomes iiin iithe iikit iiwhen iithe iimedication iiis
iiinitially
ii
prescribed.
ii
A iinurse iiis iireviewing iithe iiECG iiof iia iiclient iiwho iiis iireceiving iiIV iifurosemide iifor iiheart
iifailure. ii
, ii
The iinurse iishould iiidentify iiwhich iiof iithe iifollowing iifindings iias iian iiindication
iiof
ii
hypokalemia?
ii
a. Tall, iitented iiT iiwaves ii
b. Presence iiof iiU iiwaves ii
c. Widened iiQRS iicomplex ii
d. ST iielevation ii- iib. iiPresence iiof iiU iiwaves ii
ii
A iinurse iiis iicaring iifor iia iiclient iiand iiis iitaking iioral iimorphine iiand iidocusate iisodium. iiThe
iinurse iishould iiinstruct iithe iiclient iithat iitaking iithe iidocusate iisodium iidaily iican iiminimize
iiwhich iiof iithe iifollowing iiadverse iieffects iiof iimorphine? ii
ii
a. Constipation ii
b. Drowsiness ii
c. Facial iiflushing ii
d. Itching ii- iia. iiConstipation ii
ii
Constipation iiis iia iicommon iiadverse iieffect iiof iimorphine iithat iican iibe iiminimized iiby
iitaking ii
ii
docusate iisodium, iia iistool iisoftener iithat iipromotes iieasier iievacuation iiof iistool
iiby
ii
increasing iiwater iiand iifat iiin iithe
iiintestine.
ii
A iinurse iiis iiplanning iicare iifor iia iiclient iiwho iiis iireceiving iimannitol iivia iicontinuous iiIV
iiinfusion. ii
ii
The iinurse iishould iimonitor iifor iiwhich iiof iithe iifollowing iiadverse
iieffects?
ii
ii
a. iiWeight
iiloss
ii
b. iiIncreased iiintraocular
iipressure
ii
c. iiAuditory
iihallucinations
d. iiBibasilar iicrackles ii- iid. iiBibasilar
iicrackles
ii
Mannitol, iian iiosmotic iidiuretic, iican iiprecipitate iiheart iifailure iiand iipulmonary
iiedema, ii
therefore, iithe iinurse iishould iirecognize iilung iicrackles iias iian iiindication iiof iia
iipotential ii
ii
complication iiand iistop iithe
iiinfusion.
ii
ii ii ii ii ii ii ii
(questions) verified correct answers latest
ii ii ii ii ii
update already pass 100% accurate
ii ii ii ii ii
ii
A iinurse iiis iiproviding iidischarge iiinstructions iito iia iiclient iiwho iihas iiheart iifailure iiand iia
iinew ii
ii
prescription iifor iicaptopril. iiWhich iiof iithe iifollowing iiclient iistatements iiindicates
iian
ii
understanding iiof iithe
iiteaching?
ii
a. "I iishould iitake iithis iimedication iiwith iifood." ii
b. "I iishould iitake iinaproxen iiif iiI iidevelop iijoint iipain." ii
c. "I iishould iitell iimy iiprovider iiif iiI iidevelop iia iisore iithroat." ii
d. "I iishould iiexpect iithe iimedication iito iicause iimy iiurine iito iilook iiorange." ii- iic. ii"I iishould
iitell iimy iiprovider iiif iiI iidevelop iia iisore iithroat." ii
ii
The iiclient iishould iireport iia iisore iithroat iito iithe iiprovider iibecause iithis iican iiindicate
iineutropenia, iia iiserious iiadverse iieffect iiof iicaptopril. iiNeutropenia iican iibe iireversed iiif iiit
iiis iiidentified iiearly iiand iithe iimedication iiis iipromptly iidiscontinued. ii
ii
A iinurse iiis iiproviding iiteaching iito iia iiclient iiwho iihas iipeptic iiulcer iidisease iiand iiis iito
iistart iia ii
new iiprescription iifor iisucralfate. iiWhich iiof iithe iifollowing iiactions iiof iisucralfate iishould
iithe ii
ii ii
nurse iiinclude iiin iithe
iiteaching?
ii
ii
a. iiDecreases iistomach iiacid iiand
iisecretion
ii
b. iiNeutralizes iiacid iiin iithe
iistomach
ii
c. iiForms iia iiprotective
iibarrier
d. iiTreats iiulcers iiby iieradicating iiH. iipylori ii- iiC. iiFor iia iia iiprotective iibarrier iiover
iiulcers
ii
Secretions iiby iithe iiparietal iichief iicells, iihydrochloric iiacid iiand iipepsin, iican iifurther
iiirritate ii
the iiulcerated iiareas. iiSucralfate, iia iimucosal iiprotectant, iiforms iia iigel-like iisubstance
iithat ii
ii
coats iithe iiulcer, iicreating iia iibarrier iito iihydrochloric iiacid iiand
iipepsin.
ii
,A iinurse iiis iiproviding iiteaching iito iia iiclient iiwho iihas iimultiple iisclerosis iiand iia iinew
iiprescription iifor iimethylprednisolone. iiWhich iiof iithe iifollowing iiinstructions iishould iithe
iinurse iiinclude? ii(SATA) ii
ii
a. Blood iiglucose iilevels iiwill iibe iimonitored iiduring iitherapy ii
b. Avoid iicontact iiwith iipeople iiwho iihave iiknown iiinfections ii
c. Take iithe iimedication ii1 iihr iibefore iibreakfast ii
d. Decrease iidietary iiintake iiof iifoods iicontaining iipotassium ii
e. Grapefruit iijuice iican iiincrease iithe iieffects iiof iithe iimedication ii- iia. iiBlood iiglucose
iilevels iiwill iibe iimonitored iiduring iitherapy ii
b. iiAvoid iicontact iiwith iipeople iiwho iihave iiknown iiinfections ii
e. iiGrapefruit iijuice iican iiincrease iithe iieffects iiof iithe iimedication ii
ii
a. The iinurse iishould iimonitor iithe iiclient iifor iihyperglycemia iiwhile iiproviding
iimethylprednisolone iito iithe iiclient. iiGlucocorticoids, iisuch iias iimethylprednisolone,
iiincrease iiserum iiglucose iilevels iiand iican iirequire iimanagement iiwith iiinsulin iior
iiantihyperglycemia. ii
b. The iinurse iishould iiinstruct iithe iiclient iito iiavoid iiexposures iito iiinfectious iiagents,
iisuch iias iicontact iiwith iithose iiwho iihave iiactive iiinfections iior iiillnesses. iiGlucocorticoids,
iiwhich iias iimethylprednisolone, iidepress iithe iiimmune iisystem, iiplacing iithe iiclient iiat iian
iiincreased iirisk iifor iideveloping iian iiinfection. ii
e. iiThe iinurse iishould iiin iistrict iithe iiclient iithat iigrapefruit iiand iigrapefruit iijuice iican
iiincrease iithe iilevel iiof iimethylprednisolone iiin iithe iibody. ii
ii
The iinurse iiis iiproviding iidischarge iiteaching iiabout iihandling iimedication iito iia iiclient iiwho
iiis ii
ii
to iicontinue iitaking iioral iitransmucosal iifentanyl iiraspberry-flavored iilozenges iion iia
iistick.
ii
Which iiof iithe iifollowing iiinformation iishould iithe iinurse iiinclude iiin iithe
iiteaching?
ii
a. Chew iion iithe iimedication iistick iito iirelease iithe iimedication ii
b. Leave iithe iimedication iistick iiin iione iilocation iiof iithe iimouth iiuntil iimelted ii
c. Allow iithe iimedication ii1 iihr iifor iithe iianalgesia iieffects iito iibegin ii
d. Store iiunused iimedication iisticks iiin iia iistorage iicontainer ii- iid. iiStore iiunused
iimedication iisticks iiin iia iistorage iicontainer ii
ii
The iinurse iishould iiinstruct iithe iiclient iito iistore iiunused, iior iipartially iiused, iimedications
iisticks ii
ii
in iithe iisafe iistorage iicontainer iithat iicomes iiin iithe iikit iiwhen iithe iimedication iiis
iiinitially
ii
prescribed.
ii
A iinurse iiis iireviewing iithe iiECG iiof iia iiclient iiwho iiis iireceiving iiIV iifurosemide iifor iiheart
iifailure. ii
, ii
The iinurse iishould iiidentify iiwhich iiof iithe iifollowing iifindings iias iian iiindication
iiof
ii
hypokalemia?
ii
a. Tall, iitented iiT iiwaves ii
b. Presence iiof iiU iiwaves ii
c. Widened iiQRS iicomplex ii
d. ST iielevation ii- iib. iiPresence iiof iiU iiwaves ii
ii
A iinurse iiis iicaring iifor iia iiclient iiand iiis iitaking iioral iimorphine iiand iidocusate iisodium. iiThe
iinurse iishould iiinstruct iithe iiclient iithat iitaking iithe iidocusate iisodium iidaily iican iiminimize
iiwhich iiof iithe iifollowing iiadverse iieffects iiof iimorphine? ii
ii
a. Constipation ii
b. Drowsiness ii
c. Facial iiflushing ii
d. Itching ii- iia. iiConstipation ii
ii
Constipation iiis iia iicommon iiadverse iieffect iiof iimorphine iithat iican iibe iiminimized iiby
iitaking ii
ii
docusate iisodium, iia iistool iisoftener iithat iipromotes iieasier iievacuation iiof iistool
iiby
ii
increasing iiwater iiand iifat iiin iithe
iiintestine.
ii
A iinurse iiis iiplanning iicare iifor iia iiclient iiwho iiis iireceiving iimannitol iivia iicontinuous iiIV
iiinfusion. ii
ii
The iinurse iishould iimonitor iifor iiwhich iiof iithe iifollowing iiadverse
iieffects?
ii
ii
a. iiWeight
iiloss
ii
b. iiIncreased iiintraocular
iipressure
ii
c. iiAuditory
iihallucinations
d. iiBibasilar iicrackles ii- iid. iiBibasilar
iicrackles
ii
Mannitol, iian iiosmotic iidiuretic, iican iiprecipitate iiheart iifailure iiand iipulmonary
iiedema, ii
therefore, iithe iinurse iishould iirecognize iilung iicrackles iias iian iiindication iiof iia
iipotential ii
ii
complication iiand iistop iithe
iiinfusion.
ii
